Zai Lab Limited
-
Ticker
ZLAB
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 501-1000 Employees
- Based in Pudong, China
Zai Lab (NASDAQ:ZLAB) is an innovative commercial-stage biopharmaceutical company focused on bringing transformative medicines for cancer, infectious and autoimmune diseases to patients in China and around the world. To quickly target the large, fast-growing segments of China’s pharmaceutical market and address unmet medical needs, Zai Lab’s experienced team has secured partnerships with
…More leading global biopharma companies, generating a broad pipeline of innovative drug candidates. Zai Lab has also built an in-house team with strong drug discovery and translational research capabilities, aiming to establish a global pipeline of proprietary drug candidates against targets in their focus areas. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its portfolio in order to impact human health worldwide.
REPORT RATINGS
5.0 / 5.0 (1)
Zai Lab Limited reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Zai Lab Limited
Most Recent Responsibility Report
MOST RECENT
2023 ESG Report
Report Locked. Zai Lab Limited has reached its limit for free report views.
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Zai Lab Limited Sustainability Report, Zai Lab Limited Corporate Social Responsibility Report, Zai Lab Limited CSR Report, Zai Lab Limited Corporate Responsibility, Zai Lab Limited CR Report, Zai Lab Limited Citizenship Report, Zai Lab Limited ESG Report, and Zai Lab Limited Environmental Report online.